New partnership combines Shilpa Biologicals’ development and manufacturing capabilities with SteinCares’ regional commercialization platform Collaboration aims to expand patient access to cost-effective treatments and reinforces SteinCares’ leadership in biosimilars...
San Jose, Costa Rica, January 19th, 2026 — SteinCares announced today that Moody’s Investors Service has assigned the company an AA credit rating with Stable outlook, highlighting its solid financial position, resilient business model, and disciplined operational...
This deal strengthens SteinCares’ leadership in the biosimilar segment across Latin America with this treatment for diverse ophthalmological diseases. The partnership will result in significant cost savings for institutions in the region by providing access to a...
This strategic partnership brings an innovative intravenous iron replacement therapy to Ecuador, the Dominican Republic, Guatemala, Chile, Panama and soon in Costa Rica — offering a safe and effective treatment alternative for patients. The expanded collaboration is a...
Strategic alliance drives growth, launching Metoject in Costa Rica, Dominican Republic, Guatemala and Panama, following successful commercialization in Colombia, Chile, and Ecuador. This expanded collaboration highlights SteinCares’ strategic role as a bridge between...
